Abstract. This study investigated the distribution of neutrophil gelatinase-associated lipocalin (NGAL) and neutrophil gelatinase-associated lipocalin receptor (NGALR) in human embryonic, fetal and normal adult tissues. Tissue microarray technology was used to perform immunohistochemical examination on human embryos, fetuses at 4-22 weeks of gestation and adult tissue specimens. Results demonstrated that during the development of the nervous system, NGALR was prevalent in the neural tube and cerebrum, and NGAL was only detected in the stellate cells of the cerebrum and the Purkinje cells of the cerebellum. NGAL and NGALR were expressed in the lung alveolar epithelium and in the gastrointestinal tract in embryos, but were almost undetectable in later developmental stages. In the embryonic adrenal glands, the two proteins demonstrated moderate positivity in the cortex and the medulla. In adults, NGAL was particularly present in the cells of the inner and outer layers of the cortex and was absent in the medulla, while NGALR exhibited strong positivity in the cortex and the medulla. Evident expression of NGAL and NGALR was observed throughout development in the neutrophil-rich sites, the renal tubule epithelium and certain gland epithelia of the gastrointestinal tract, but was undetectable in the heart, liver and thyroid gland. Taken together, these results demonstrated that the expression of NGAL and NGALR was time-specific and highly tissue-specific. Correlations between their expression in embryogenesis and carcinogenesis should be examined.
Introduction
Neutrophil gelatinase-associated lipocalin (NGAL), a member of the lipocalin family of small secreted proteins, was originally identified as a protein stored in specific granules of human neutrophils (1) . Besides being expressed in neutrophils, NGAL is expressed in the majority of tissues normally induced in epithelial cells during inflammation (2, 3) , delivering iron to cells during formation of the tubular epithelial cells of the primordial kidney (4) , and protecting against acute ischemic renal injury, thus it is involved in apoptosis as a survival factor (5, 6) . NGAL has been identified in a variety of normal and pathological human tissues. A cell type-specific pattern of expression has been observed in the bronchus, stomach, small intestine, pancreas, kidney, prostate gland and thymus (3) . Expression of NGAL has also been detected in human cancers, including colorectal (2), breast (7), pancreatic (8) , bladder (9) , ovarian (10) , esophageal squamous cell carcinoma (11) and gastric carcinoma (12) , and its homologue is also expressed during chicken embryo development in hypertrophic cartilage (13) , and in the hypertrophic region of growth plate cartilage in developing rat embryos (14) .
The receptor of the homologue of NGAL in mice 24 p3 (24 p3R) was identified and the corresponding human receptor (NGALR) was also found (15, 16) . NGALR was reported to have a function dependent on the status of NGAL. NGAL and NGALR constitute a novel iron delivery pathway that is crucial to the survival, growth and maturation of cells (17) . This observation led investigators to explore the co-expression of NGAL and NGALR. NGALR expression in esophageal squamous cell carcinoma was found to be significantly higher compared to normal esophageal epithelium (18) . More recently, we found that NGAL and NGALR might be involved in the progression of esophageal squamous cell carcinoma and gliomas, and their expression can be considered as independent prognostic factors in these tumors (19, 20) . However, little is known regarding the systematic demonstration of NGAL and NGALR expression in various human organs at different developmental stages.
To improve the understanding of the function of these two proteins in human development, we aimed to demonstrate the expression of NGAL and NGALR in human embryo, fetus and normal adult tissues by employing tissue microarray technology and immunohistochemical staining.
Materials and methods
Samples. Forty human samples consisting of 3 embryos, 11 fetuses and 26 postnatal specimens were examined in the study (Table I) . Intact embryos and fetuses were obtained from the Department of Gynaecology and Obstetrics, Central Hospital of Shantou, Shantou, China. Samples were collected from 14 healthy pregnant females undergoing elective termination of pregnancy at 4-22 weeks of gestation. Specimens were fixed immediately in 4% buffered-formalin solution, and visible organs were embedded in paraffin blocks. Normal human tissue sections (from autopsy specimens) were obtianed from the Department of Forensic Medicine, Shantou University Medical College, Shantou, China. The specimens were collected between 2002 and 2005. Tissues from the cerebellum, cerebrum, thymus, lung, trachea, heart, esophagus, stomach, large intestine, small intestine, liver, pancreas, kidney, spleen, thymus, lymph-node, pituitary, adrenal gland and thyroid gland were collected. The study was conducted with permission from the local ethics committees.
Construction of tissue microarrays. Representative regions from each tissue were selected from hematoxylin-and eosin-stained sections and marked on individual paraffin blocks. Samples were selected from the specimens with a large quantity of tissue available for correlative studies. Two tissue cores, measuring 1.8 mm in diameter and ranging in length from 1.0 to 3.0 mm depending on the depth of the tissue in the donor block, were obtained from each specimen. Each core was precisely arrayed into a new paraffin block. The microarrays were serially sectioned (4 µm), and stained with hematoxylin and eosin to verify tissue sampling and completeness. Unstained sections were baked overnight at 56˚C prior to immunohistochemistry.
Immunohistochemical staining. Slides were dried in an oven (55-60˚C) and the paraffin was removed through several changes of xylene. The slides were hydrated through a series of graded alcohol to water followed by incubation with 3% hydrogen peroxide for 10 min. For antigen retrieval, the slides were autoclaved in 0.01 M citrate buffer (pH 6.0) at 120˚C for 3 min. Sections were then incubated with 10% normal goat serum in phosphate-buffered saline (PBS) for 15 min at room temperature to block non-specific binding. After rinsing with PBS, the slides were incubated at 4˚C overnight with mouse anti-human NGAL monoclonal antibody (1:50 dilution; R&D Systems, Minneapolis, MN, USA) or rabbit anti-human NGALR polyclonal antibody (1:10 dilution, Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China). After further rinsing with PBS, the tissue sections were incubated for 15 min at room temperature with polymer helper solution (Polymer Detection System kit, Golden Bridge International, Inc., Mukilteo, WA, USA), and then rinsed with PBS. The slides were then incubated for 20 min at room temperature with streptavidin peroxidase-conjugated goat anti-mouse IgG (Polymer Detection System kit). Subsequently, the slides were stained with 0.003% 3,3-diaminobenzide tetrahydrochloride and 0.005% hydrogen peroxide in 0.05 M Tris-HCl (pH 7.2), and counterstained using Mayer's hematoxylin prior to being dehydrated and mounted. A metastatic esophageal carcinoma previously demonstrated to have immunoreactivity was used as a positive control in each series of experiments (11) . Negative controls were prepared by substituting PBS for primary antibody.
NGAL-positive samples were defined as those demonstrating brown signals in the cell membrane and cytosol. Immunoreactivity was measured semiquantitatively using a scale from (-) to (+++), where (-) represented no detectable immunostaining; (+) that <25% of the cells were reactive; (++) that >50% of the cells were reactive; and (+++) that >50% of the cells were reactive. Finally, scales of (-), (+), (++) and (+++) were defined as negative, weakly positive, moderately positive and strongly positive staining, respectively.
Results

The distribution of NGAL and NGALR in normal human tissues as determined by immunostaining.
Expression of NGAL and NGALR was homogeneous in the postnatal stages; however, differential expression was observed during embryonic and fetal development (Table II) .
Nervous system. In the development of the nervous system, the expression of NGAL was undetectable in the early embryos, but detectable in the later developmental stages, and NGALR protein was detected throughout human development. In the early embryos, the neuroepithelium of the neural tube demonstrated NGAL-negative (Fig. 1A) and NGALR-positive expression (Fig. 1B) . In the fetuses and adults, NGAL and NGALR immunoreactivities were detected in stellate cells of the cerebrum, but not in glial cells (Fig. 1C and D) . In the cerebellum, no immunoreactivity was found in any cells of the Purkinje cell, granular or molecular layer at 8-12 weeks' gestation ( Fig. 1E and F) ; however, the Purkinje cells demonstrated pronounced immunoreactivity in the later developmental stages ( Fig. 1G and H) .
Alimentary system. The expression pattern of NGAL and NGALR was similar to the gastrointestinal development. At 6-8 weeks' gestation, the two proteins were expressed in cells of the gastrointestinal tract ( Fig. 2A and B) . In later developmental stages, the proteins were observed in certain cells of the glandular epithelium, including the Paneth's and gastric parietal cells ( Fig. 2C and D) . In the liver, NGAL and NGALR were weakly positive. In the pancreas, the acini and tubular epithelium of the glandular pancreatic tissue Table II . Distribution of NGAL and NGALR in normal human tissues determined by immunostaining. Immunoreactivity was measured semi-quantitatively using a scale from (-) to (+++). (-), no immunostaining; (+), <25% of the cells were reactive; (++), 25-50% of the cells were reactive; (+++), >50% of the cells were reactive. Scales of (-), (+), (++) and (+++) were defined as negative, weakly positive, moderately positive and strongly positive staining, respectively. NGAL, neutrophil gelatinase-associated lipocalin; NGALR, neutrophil gelatinase-associated lipocalin receptor; N/A, no analysis exhibited NGAL-negative (Fig. 2E ) and NGALR-positive expression (Fig. 2F) .
Endocrine system. During the development of the endocrine system, the expression of NGAL and NGALR was detectable in certain cells of the anterior pituitary, but undetectable in the follicular and C-cells of the thyroid gland ( Fig. 3A and B) . In the adrenal gland, the two proteins demonstrated a moderately positive reaction at 8-22 weeks' gestation in the cortex and the medulla (Fig. 3C and D) . However, in later stages of development, NGAL was particularly demonstrated in cells of the inner and outer layers of the cortex, decreased in the zona fasciculata and entirely absent in the medulla (Fig. 3E) , while NGALR demonstrated strong positivity in the cortex and the medulla (Fig. 3F) .
Expression of NGAL and NGALR in other systems.
In the cardiovascular system, NGAL and NGALR produced no or weak reactivity in the vascular endothelial and myocardial cells ( Fig. 4A and B) . In the respiratory system, NGAL and NGALR were most prevalent in the epithelium of the alveolar gland in the early embryos ( Fig. 4C and D) , but not in the cells of the lung during later developmental stages. In the development of the genitourinary system, there was no evident difference between NGAL and NGALR expression. In the kidney, the two proteins were expressed in epithelial cells of the pars convoluta of the proximal tubule, and strongly expressed in epithelium of the distal tubule and the collecting duct ( Fig. 4E and F) . Bladder epithelium and prostate tissues were all negative. In the immune system, NGAL and NGALR were undetectable in the lymphocytes, but evidently demonstrated in the Hassall's corpuscle epithelial cells of the thymus (Fig. 4G and H) .
Discussion
In the present study, we demonstrated that NGAL and NGALR were expressed in the epithelium of the renal tubule, the kidney, the thymus and the adrenal gland, but were not detectable in the heart, liver and thyroid gland, which was consistent with find- ings from a previous study demonstrating NGAL expression in normal human tissues (3) . It was reported that in developing muscle fibers, a NGAL homologue was found in the hypertrophic cartilage during chicken embryo development (13) and in the hypertrophic region of growth plate cartilage in developing rat embryos (14) . Mallbris et al investigated the expression of NGAL in human skin embryonic development and reported that the embryonic expression of NGAL was induced in the interfollicular epidermis at 20-24 weeks of gestational age, but thereafter progressively receded towards the hair follicles (21) .
In this study, we revealed that NGAL was expressed in the gastrointestinal tract during human embryo development. These findings suggest that NGAL is an evolutionarily conserved protein.
We found that NGAL and NGALR demonstrated different expression patterns in human embryonic, fetal and normal adult tissues, and their expression was adapted to become tissue and cell-specific throughout human development. The two proteins were weakly-positive or negative in normal cells of the thyroid gland, liver, heart and blood vessels, but they were abundant in the spleen and adrenal gland, and at the cell level, they were specific to lymphocytes and the epithelium of the renal tubule. In addition to a broad range of simple epithelial cell types, we found that the proteins were also expressed in stratified epithelia. For example, in the skin, mature cells of the outermost stratified layers exhibited a distribution of NGAL, which was inconsistent with results from a previous study (11) . The expression of NGAL and NGALR does not appear to follow any morphogenetic pattern, however, colocalization with regards to cell function can be identified at closer examination.
Expression of NGAL and NGALR were also found to be time-specific during human growth and development. The proteins were expressed in the epithelium of the lung alveolus and gastrointestinal tract in the embryos, but were almost undetectable in the later developmental stages. In the embryonic adrenal gland, the cortex and medulla demonstrated a moderately positive reaction. In the adult tissues, NGAL was particularly present in the cells of the inner and outer layers of the cortex, but was absent in the medulla. Additionally, a pronounced expression pattern for NGAL was undetectable throughout the neural tube, but was detected in the stellate cells of the cerebrum and the Purkinje cells of the cerebellum in postnatal stages. It has been reported that the expression of NGAL was induced in the interfollicular epidermis at 20-24 weeks of gestational age, but thereafter progressively receded towards the hair follicles (21) . Although there is no precise mechanism to explain the reason for the upregulation of the NGAL protein level in a number of normal tissues, as observed at early developmental stages, we speculate that NGAL might be involved in cell-cell interactions, cell division and/or cell growth, due to the high demand for those biological behaviors during development.
Lipocalins have been extensively used as biochemical markers for diseases. The clinical indications are associated with almost any field of medicine, including inflammatory disease, cancer, lipid disorders and kidney disease (22) . Previous studies have demonstrated that overexpression of NGAL is involved in the progression of tumors (2,7-12). In cancers of the alimentary system, NGAL was upregulated in human colorectal and gastric cancer (2, 12) . Results from our study revealed that the glandular epithelium of the normal adult gastrointestinal tract is negative for NGAL expression, but a pronounced positive staining was observed throughout the gastrointestinal tract at early fetal stages. Furthermore, NGAL was detected in the epithelium of the lung alveolus in embryos and A549 cells, a lung carcinoma cell line (6), but was almost undetectable in the adult lung tissue. Thus, NGAL immunoreactivity was found in cells of early fetal stages and in malignant cells, but was negative in the corresponding adult tissues, suggesting that there was a specific correlation between NGAL expression in certain malignant cells and in the corresponding normal cells from early developmental stages. We speculate that there may be a correlation between NGAL expression and the processes of embryogenesis and carcinogenesis.
In conclusion, the immunohistochemical observations in the present study are the first systematic demonstration of the immunoreactive presence of NGAL and NGALR in human embryonic, fetal and normal adult tissues. Through analyses of the differential expression, it was found that the expression of NGAL and NGALR is highly tissue-and time-specific.
